Disposable Blood Bags Market Updates by 2031
Disposable blood bags are used for collection, storage, transfusion and transportation of human blood and its components. These are closed systems and hence avoid the chances of contamination. These bags contain anticoagulant solutions like CPD and CPDA. CPD is used for blood storage up to 21 days whereas CPDA is used for enhanced storage up to 35 days. CPD-SAGM anticoagulant solution variant for red blood storage up to 42 days. The blood bag has tamper proof, safe and easy to open ports for easy transfusion and helps in prevention of contamination.
The disposable blood bags market is anticipated to grow in the forecast period owing to key factor such as growth in number of blood transfusion procedures, surge in incidence of road accidents,
rise in prevalence of blood-related diseases and increasing number of government initiatives to promote blood donation, blood collection, and storage. However, factors like risks associated to blood transfusion
and low number of blood donations in underdeveloped regions.
The "Global Disposable Blood Bags Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global disposable blood bags market with detailed market segmentation by product, end user and geography. The global disposable blood bags market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Disposable blood bags market players and offers key trends and opportunities in the market.
The global disposable blood bags market is segmented on the basis of product, and end user. Based on product, the disposable blood bags market is segmented collection bags and transfer bags. The collection bags segment consists of CPDA blood bags and CPD/SAGM blood bags. Based on end user the disposable blood bags market is segmented as blood banks, hospitals, ambulatory centers and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global disposable blood bags market based on product, and end user. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The disposable blood bags market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the disposable blood bags market in the forecast period, due to increasing number of multimillion hospitals, nursing homes, and ambulatory centers, growing demand for disposable blood bags and growing prevalence of blood disorders. However, Asia Pacific region is expected to be the fastest growing region owing to rising number of trauma incidences, and the increasing number of blood transportation and transfusion procedures.
The report analyzes factors affecting disposable blood bags market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Disposable blood bags market in these regions.
The report also includes the profiles of key Disposable blood bags companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the disposable blood bags market include, Grifols, Fresenius Kabi AG, Span Healthcare Private Limited, TERUMO BCT, INC., Neomedic Limited, MACOPHARMA, HLL Lifecare Limited, Teleflex Incorporated, INNVOL MEDICAL INDIA LTD., and HAEMONETICS CORPORATION among others.
REGIONAL FRAMEWORK
MARKET PLAYERS
The disposable blood bags market is anticipated to grow in the forecast period owing to key factor such as growth in number of blood transfusion procedures, surge in incidence of road accidents,
rise in prevalence of blood-related diseases and increasing number of government initiatives to promote blood donation, blood collection, and storage. However, factors like risks associated to blood transfusion
and low number of blood donations in underdeveloped regions.
The "Global Disposable Blood Bags Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global disposable blood bags market with detailed market segmentation by product, end user and geography. The global disposable blood bags market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Disposable blood bags market players and offers key trends and opportunities in the market.
The global disposable blood bags market is segmented on the basis of product, and end user. Based on product, the disposable blood bags market is segmented collection bags and transfer bags. The collection bags segment consists of CPDA blood bags and CPD/SAGM blood bags. Based on end user the disposable blood bags market is segmented as blood banks, hospitals, ambulatory centers and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global disposable blood bags market based on product, and end user. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The disposable blood bags market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the disposable blood bags market in the forecast period, due to increasing number of multimillion hospitals, nursing homes, and ambulatory centers, growing demand for disposable blood bags and growing prevalence of blood disorders. However, Asia Pacific region is expected to be the fastest growing region owing to rising number of trauma incidences, and the increasing number of blood transportation and transfusion procedures.
The report analyzes factors affecting disposable blood bags market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Disposable blood bags market in these regions.
The report also includes the profiles of key Disposable blood bags companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the disposable blood bags market include, Grifols, Fresenius Kabi AG, Span Healthcare Private Limited, TERUMO BCT, INC., Neomedic Limited, MACOPHARMA, HLL Lifecare Limited, Teleflex Incorporated, INNVOL MEDICAL INDIA LTD., and HAEMONETICS CORPORATION among others.
REGIONAL FRAMEWORK
Disposable Blood Bags Market Report Analysis
Disposable Blood Bags Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Grifols
- Fresenius Kabi AG
- Span Healthcare Private Limited
- TERUMO BCT INC
- Neomedic Limited
- MACOPHARMA
- HLL Lifecare Limited
- Teleflex Incorporated
- INNVOL MEDICAL INDIA LTD
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Product Type
- Syringe Infusion Pumps and Large Volume Infusion Pumps
By End User
- Veterinary Hospitals and Veterinary Clinics
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Disposable Blood Bags Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Grifols
2. Fresenius Kabi AG
3. Span Healthcare Private Limited
4. TERUMO BCT, INC.
5. Neomedic Limited
6. MACOPHARMA
7. HLL Lifecare Limited
8. Teleflex Incorporated
9. INNVOL MEDICAL INDIA LTD.
10. HAEMONETICS CORPORATION
1. Grifols
2. Fresenius Kabi AG
3. Span Healthcare Private Limited
4. TERUMO BCT, INC.
5. Neomedic Limited
6. MACOPHARMA
7. HLL Lifecare Limited
8. Teleflex Incorporated
9. INNVOL MEDICAL INDIA LTD.
10. HAEMONETICS CORPORATION